On November 9th, during the 6th China International Import Expo (CIIE), Singclean Medical successfully entered into a strategic cooperation agreement with BD Medical Pharmaceutical Systems. The agreement encompasses the signing of a 300 million yuan contract for the supply of pre-filled hyaluronic acid injection syringes, with the goal of delivering a higher quality and safer experience for tens of millions of beauty enthusiasts. In the future, Singclean Medical and BD Medical will collaborate to elevate standards in medical cosmetic skin services, jointly establish a benchmark for quality medical aesthetics, and introduce more Chinese-made medical beauty products to the global market. Sun Weiqing, General Manager of Hangzhou Singclean Medical, and Jiang Wei, Vice President of Strategic Innovation and Business Excellence for BD Medical in Greater China, attended the signing ceremony.
A 3 million yuan contract signed, benefiting tens of millions of beauty seekers.
At the CIIE, Singclean Medical and BD Medical signed a strategic cooperation agreement, focusing on pre-filled syringe products primarily featuring Hylok. This agreement includes a 3 billion yuan contract, with Singclean Medical expected to provide a higher quality beauty experience to tens of millions of beauty seekers. By utilizing the Hylok glass pre-filled syringe customized by BD Medical for viscous medications, Singclean Medical will offer filler products with significantly higher resistance to pull-out force and torque compared to similar products. With Hylok, Singclean Medical effectively addresses the common and challenging issue of leakage when healthcare professionals use pre-filled hyaluronic acid products, making it an ideal solution for hyaluronic acid injections.
However, BD pre-fillable syringe is only one part of our product quality control process for our hyaluronate gel, from the raw materials, filling, sterilization, labeling to packing, every step for the process is strictly examined by Singclean Medical.
Elevating the quality of medical aesthetics, empowering Chinese manufacturing to go global
Singclean Medical's cooperation with BD Medical Pharmaceutical Systems in the field of injectable medical products has a long-standing history. Singclean Medical's Singfiller and Singderm cross-linked hyaluronate gel for plastic surgery, and other medical sodium hyaluronate gel used in ophthalmology and orthopedics, have utilized glass pre-filled syringes manufactured by BD Medical. With the outstanding quality of these BD syringes, Singclean Medical's products have gained widespread recognition in both domestic and international markets.
Singfiller, a bi-phasic cross-linked sodium hyaluronate gel developed by Singclean Medical, it is produced by fully automated equipment, with more uniform particle size, more smooth injection, and more accurate shaping for doctors' fine operation. It is viscoelastic and can resist deformation and displacement caused by external forces effectively, creating a natural perfect contour. It has gained widespread acceptance across Chinese provinces, boasting a monthly average domestic sales volume surpassing 500,000 units. This product, catering to the needs of millions of medical aesthetics consumers, has secured registrations in various countries, including the European Union, the Middle East, and Southeast Asia. With exports reaching over 30 countries worldwide, Singfiller stands shoulder to shoulder with international brands in both quality and sales performance.
Singclean Medical's medical sodium hyaluronate gel for orthopedic surgery has been registered in over 40 countries. Singclean medical sodium hyaluronate gel for ophthalmology surgery has a global usage exceeding 600,000 units, providing reliable support for eye surgeries in more than 30 countries.
Hangzhou Singclean Medical's General Manager, Sun Weiqing, stated, "In recent years, with the introduction of BD's Hylok syringe, a safer and more effective injector product has been brought to a large number of beauty seekers. Consumers now have a higher injection experience, providing more opportunities for our products to go global.
The market share of the Chinese medical aesthetics market is less than 5%, but there has been a rapid growth in the demand for medical aesthetics among the general public in recent years, reflecting a trend towards democratization and easy beautification. Products using hyaluronic acid sodium for skin texture improvement, commonly known as water-light products, have officially been classified into the third category of medical products, marking a milestone in the industry.
As an upstream enterprise in the field of medical aesthetics, I believe that ensuring quality is the first step for a company to survive in the long term. Secondly, with the trend of consumption sinking and democratization, we need to pursue a globalized supply chain, achieve a certain scale, and strive for a balance between quality and cost-effectiveness to achieve greater development. Thirdly, globalization. Chinese manufacturing still has advantages globally, and the internationalization of Chinese products is a significant opportunity for our medical aesthetics industry. Therefore, Singclean Medical has always been committed to a globalized path. We have a strong market presence in South America, Europe, Southeast Asia, and the Middle East. "
